Risk reduction strategies: Surgical perspective

Lisa Renee Palko Spiguel; Nora Hansen

doi:10.1007/978-1-4614-5891-3_8

Risk reduction strategies: Surgical perspective

Lisa Renee Palko Spiguel^*, Nora Hansen

^*Corresponding author for this work

Surgery, Breast Surgery Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Breast cancer is estimated to affect over 200,000 women in the United States in 2012, accounting for up to 40,000 deaths [1]. Based on SEER database rates from 2006 to 2008, the cumulative lifetime risk of breast cancer for an average woman in the general US population is 12.29 %, with the greatest risk occurring in the sixth decade of life [1]. Although the majority of these breast cancers are sporadic, approximately 25 % of breast cancers are secondary to some inherited predisposition, commonly related to identifiable mutations in inherited genes such as BRCA1, BRCA2, CHEK2, and PTEN. Women born with these gene mutations are at a significantly higher risk of developing breast cancer over the general population, as well as other associated cancers, and do so typically at a younger age.

Original language	English (US)
Title of host publication	Management of the Patient at High Risk for Breast Cancer
Publisher	Springer New York
Pages	103-119
Number of pages	17
ISBN (Electronic)	9781461458913
ISBN (Print)	1461458900, 9781461458906
DOIs	https://doi.org/10.1007/978-1-4614-5891-3_8
State	Published - Nov 1 2013

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-5891-3_8

Fingerprint Dive into the research topics of 'Risk reduction strategies: Surgical perspective'. Together they form a unique fingerprint.

Cite this

Spiguel, L. R. P., & Hansen, N. (2013). Risk reduction strategies: Surgical perspective. In Management of the Patient at High Risk for Breast Cancer (pp. 103-119). Springer New York. https://doi.org/10.1007/978-1-4614-5891-3_8

@inbook{6a7f5c03f8004b488f1acc48d193a9b1,

title = "Risk reduction strategies: Surgical perspective",

abstract = "Breast cancer is estimated to affect over 200,000 women in the United States in 2012, accounting for up to 40,000 deaths [1]. Based on SEER database rates from 2006 to 2008, the cumulative lifetime risk of breast cancer for an average woman in the general US population is 12.29 %, with the greatest risk occurring in the sixth decade of life [1]. Although the majority of these breast cancers are sporadic, approximately 25 % of breast cancers are secondary to some inherited predisposition, commonly related to identifiable mutations in inherited genes such as BRCA1, BRCA2, CHEK2, and PTEN. Women born with these gene mutations are at a significantly higher risk of developing breast cancer over the general population, as well as other associated cancers, and do so typically at a younger age.",

author = "Spiguel, {Lisa Renee Palko} and Nora Hansen",

year = "2013",

month = nov,

day = "1",

doi = "10.1007/978-1-4614-5891-3_8",

language = "English (US)",

isbn = "1461458900",

pages = "103--119",

booktitle = "Management of the Patient at High Risk for Breast Cancer",

publisher = "Springer New York",

}

TY - CHAP

T1 - Risk reduction strategies

T2 - Surgical perspective

AU - Spiguel, Lisa Renee Palko

AU - Hansen, Nora

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Breast cancer is estimated to affect over 200,000 women in the United States in 2012, accounting for up to 40,000 deaths [1]. Based on SEER database rates from 2006 to 2008, the cumulative lifetime risk of breast cancer for an average woman in the general US population is 12.29 %, with the greatest risk occurring in the sixth decade of life [1]. Although the majority of these breast cancers are sporadic, approximately 25 % of breast cancers are secondary to some inherited predisposition, commonly related to identifiable mutations in inherited genes such as BRCA1, BRCA2, CHEK2, and PTEN. Women born with these gene mutations are at a significantly higher risk of developing breast cancer over the general population, as well as other associated cancers, and do so typically at a younger age.

AB - Breast cancer is estimated to affect over 200,000 women in the United States in 2012, accounting for up to 40,000 deaths [1]. Based on SEER database rates from 2006 to 2008, the cumulative lifetime risk of breast cancer for an average woman in the general US population is 12.29 %, with the greatest risk occurring in the sixth decade of life [1]. Although the majority of these breast cancers are sporadic, approximately 25 % of breast cancers are secondary to some inherited predisposition, commonly related to identifiable mutations in inherited genes such as BRCA1, BRCA2, CHEK2, and PTEN. Women born with these gene mutations are at a significantly higher risk of developing breast cancer over the general population, as well as other associated cancers, and do so typically at a younger age.

UR - http://www.scopus.com/inward/record.url?scp=84929589733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929589733&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5891-3_8

DO - 10.1007/978-1-4614-5891-3_8

M3 - Chapter

AN - SCOPUS:84929589733

SN - 1461458900

SN - 9781461458906

SP - 103

EP - 119

BT - Management of the Patient at High Risk for Breast Cancer

PB - Springer New York

ER -